HPV Biomarkers, Survival Linked to High-Grade Esophageal Dysplasia, Adenocarcinoma
Low expression of the HPV-related marker cyclin D1 appears to be an independent prognostic marker in Barrett high-grade dysplasia and esophageal adenocarcinoma.
Low expression of the HPV-related marker cyclin D1 appears to be an independent prognostic marker in Barrett high-grade dysplasia and esophageal adenocarcinoma.
More than half of bimanual exams, >70 percent of Pap tests in women aged 15 to 20 years unnecessary
Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites
No significant difference found in detection of CIN2+ or treatment with intervention versus usual care
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings
An updated systematic review and meta-analysis of the efficacy of HPV vaccines revealed compelling evidence for the considerable effect of HPV vaccination programs on HPV infections and cervical intraepithelial neoplasia grade 2+ (CIN2+) among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men. The review, published in The Lancet, included…
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant.
There was no increased risk for development of diabetes mellitus type 1 after vaccination for human papilloma virus.